Pinion Blog
QSBS: The Asymmetric Tax Play Underlying Angel Investing
Section 1202 can make your gains tax-free. Section 1244 can make your losses deductible against ordinary income. Together, they create one of the most asymmetric risk profiles in U.S. investing — but only if you plan for both before you write the check.
A note before we start: I'm not an accountant, a tax attorney, or a financial advisor. I might be the furthest thing from any of these things. What follows is my experience, a general overview, and my interpretation of how some federal tax provisions work for qualified small business stock (QSBS). The rules are detailed, the documentation requirements are necessary, and the stakes — on both the gain and the loss side — are high enough that you should not act on anything in this post without talking to a qualified tax professional who can look at your specific situation. Treat this as a case study that should give you ideas to discuss with your trusted advisors.
With that out of the way, let’s talk about one of the most interesting features of the U.S. tax code from an angel investor’s perspective: the way it treats investments in qualified small business stock. If you’ve been writing checks for a while, you’ve probably heard of QSBS in the context of “tax-free gains.” That’s the headline, and it’s real. But the more interesting story — the one that changes how you think about the asymmetry of angel investing — is what happens on both sides of the outcome distribution. The wins can be tax-free under Section 1202. The losses, in the right circumstances, can be deducted against ordinary income under Section 1244. Together, they create a great opportunity.
I’ve personally lived both sides of this. One investment exited and we got to take the gains tax-free. Another was written off and we got to deduct 100% of the loss directly against ordinary income. These weren’t theoretical features of the tax code — they were checks I actually wrote and outcomes I actually experienced, and they shaped how I think about the angel asset class. This piece walks through both sides of the picture, what the current rules look like after the 2025 changes, and what it all means for how you might evaluate your next investment.
Again: not tax advice. Ideas.
The upside: Section 1202 and tax-free gains
Section 1202 of the Internal Revenue Code lets noncorporate taxpayers exclude some or all of the gain on the sale of qualified small business stock, provided a long list of conditions are met. The basic idea has been around since 1993, but the provision was substantially expanded in July 2025 by the One Big Beautiful Bill Act (OBBBA), which is the framework that now applies to QSBS issued AFTER July 4, 2025. Stock issued before that date follows the older rules.
Under the post-OBBBA rules for stock issued after July 4, 2025, the exclusion is tiered based on holding period:
- Hold for at least three years: 50% of the gain is excluded
- Hold for at least four years: 75% of the gain is excluded
- Hold for at least five years: 100% of the gain is excluded
The cap on excluded gain is the greater of $15 million per issuer (up from $10 million pre-OBBBA, and indexed for inflation starting in 2027) or ten times your adjusted basis in the stock. The company must be a domestic C corporation, must have aggregate gross assets of $75 million or less at issuance (up from $50 million pre-OBBBA), and must be engaged in a qualified trade or business — which excludes things like financial services, law, health, hospitality, farming, and a few other categories. The stock has to be acquired at original issuance, not on the secondary market.
There are more requirements (the 80% active business asset test, restrictions around redemptions, state conformity issues), and they all matter. But the high-level shape is: if you wrote a check directly into a qualifying C-corp startup, held it for five or more years, and the company exited, you can potentially exclude up to $15 million or 10x your basis in gain from federal tax. That’s not a deferral. It’s an exclusion. The gain never enters your taxable income.
What it actually looked like
The deal terms I can share: we invested $50,000 in 2015 and the company exited in 2024, returning $68,000. Not a great IRR — call it roughly 3.5% annualized over nine years. As a standalone investment outcome, it's nothing to write home about.
But the QSBS treatment meaningfully improved the picture. The $18,000 gain qualified for the federal exclusion under Section 1202, which meant we kept the full gain rather than handing 20-23% of it back in federal tax. That's not life-changing money in absolute terms, but it's a material improvement on a return that was otherwise barely beating inflation. And it's the kind of improvement that adds up across a portfolio when you're writing checks consistently into qualifying companies — every realized gain comes back at full value rather than getting trimmed at the federal level.
The point isn't that QSBS turns mediocre outcomes into great ones. It doesn't. It's that QSBS removes a layer of friction from the wins, large and small, which compounds across an active angel practice. A modest win that comes back federal-tax-free is still a better outcome than the same win taxed at long-term capital gains rates — and a big win, if you ever catch one, becomes substantially bigger.
There are a few things I’d flag from that experience for any angel approaching this for the first time:
The documentation matters more than you think. You need to be able to demonstrate the company qualified at issuance — gross asset level, business activity, C-corp status, original issue. Some founders are diligent about producing QSBS attestations at the time of investment. Many aren’t. If you can get the company to confirm QSBS eligibility in writing at the time you invest, do it. Years later, when you’re trying to claim the exclusion, reconstructing this from old SAFE notes and cap table records is harder than you’d guess.
State conformity is uneven. Section 1202 is a federal provision. Some states fully conform (your state follows the federal exclusion), some don’t conform at all (the gain is fully taxable at the state level), and some partially conform. As of mid-2025, California, Alabama, Mississippi, New Jersey, and Pennsylvania were notable non-conformers, with Hawaii and Massachusetts partially conforming. If you’re in a non-conforming state, your effective benefit is smaller than the headline federal number suggests. Texas, where I’m based, has no state income tax, which makes the federal exclusion the whole picture.
The clock matters. The five-year holding period (or three- or four-year for partial exclusions under post-OBBBA rules) is calculated from the date the stock was actually issued to you, not the date the company was founded or the round closed. If you’re approaching an exit and you’re close to a tier threshold, the timing can be worth millions. There’s also a Section 1045 rollover provision that lets you reinvest QSBS proceeds into new QSBS within 60 days and tack on the holding period, which is worth knowing about if you’re going to be forced into an early sale.
The downside: Section 1244 and ordinary loss treatment
Here’s the part most angel investors don’t know about, and the part that genuinely changed how I think about the asymmetry of the asset class.
When a normal stock investment goes to zero, the loss is treated as a capital loss. Capital losses are first offset against capital gains, and then — if you have leftover losses — you can deduct $3,000 per year against ordinary income, with the rest carried forward indefinitely. If you’re an active angel and you have a portfolio company that goes to zero with no offsetting capital gains that year, you’re effectively writing off the loss at $3,000 per year for what could be many years. The economics are punishing.
Section 1244 of the IRC, which is separate from Section 1202 but can apply to the same investment, allows individual taxpayers to treat losses on qualifying small business stock as ordinary losses rather than capital losses, up to $50,000 per year for individuals or $100,000 per year for married couples filing jointly. Anything above those limits is treated as a capital loss in the normal way, but the portion that qualifies under 1244 deducts directly against ordinary income — the same income bucket your wages, interest, dividends, and 1099 income flow into.
To qualify for Section 1244 treatment, the stock generally needs to meet a few conditions:
- It must be stock in a domestic corporation that was a “small business corporation” at the time of issuance, meaning the corporation had received less than $1 million in aggregate money and property for stock issuances at the time the stock was issued.
- The stock must have been issued in exchange for money or property — not services, and not other stock or securities.
- The corporation must derive more than 50% of its gross receipts from active business operations rather than passive sources (royalties, rents, dividends, interest, etc.) over the relevant testing period. There’s an exception when the corporation’s deductions exceed its gross income, which is common for early-stage startups.
- The shareholder claiming the loss must be the original purchaser of the stock and must be an individual or a partnership (not a corporation, trust, or estate).
Worth noting: the corporation’s $1 million capitalization threshold for 1244 purposes is a much lower bar than the $75 million gross asset threshold for QSBS. Many investments that qualify for QSBS also qualify for 1244, but the 1244 qualification has to be tested at the moment of your stock issuance, before the company exceeds the $1 million threshold.
What it actually looked like
The deal terms I can share: we invested $100,000 across 2023 and 2024 in a C corporation that qualified under Section 1244. The company ceased operations in 2025, and we'll claim the full $100,000 loss against ordinary income on our 2026 return — a year in which we have ordinary income we'd otherwise be paying tax on.
That timing is what makes the provision meaningful in practice. Without 1244, the $100,000 would be a capital loss with no offsetting gains in 2026, deductible at $3,000 per year against ordinary income and otherwise carried forward indefinitely. With 1244, the full $100,000 deducts against ordinary income in the year we recognize the loss. We're not recovering the original investment — that money is gone — but we are recovering a meaningful portion of it through tax savings on income we'd be paying on anyway.
The lesson I took from this experience is that 1244 is most valuable when you have ordinary income to offset in the year you recognize the loss. If a portfolio company is winding down and you have flexibility on the timing of recognition, it's worth coordinating with your CPA on which tax year produces the best result. The provision is generous, but the value depends on what's on the rest of your return.
The thing this experience changed in my head is the asymmetry it creates with QSBS. Think about what it means in combination:
- If the investment wins, you can potentially exclude up to $15 million (or 10x basis) of gain from federal tax under Section 1202.
- If the investment loses, you can potentially deduct up to $50K/$100K per year of the loss against ordinary income under Section 1244.
The wins are tax-free. The losses are tax-advantaged. The asset class is already asymmetric in its raw return profile because of the power law — the winners are uncapped while the losers are capped at -1x. The tax code amplifies that asymmetry. After-tax, a winning angel investment retains more of its gain than almost any other investment category in the U.S., and a losing angel investment recovers more of its loss against your highest-rate income.
Practical things worth knowing
A few things I wish I’d understood sooner:
Not every angel investment qualifies for either provision. The structures are specific. C corps, original issuance, qualifying business activity, gross asset thresholds, holding periods. SAFEs that convert into qualifying stock can work, but the conversion mechanics matter. If you’re investing through an LLC, the LLC structure itself is generally disqualifying for both 1202 and 1244 — unless the underlying entity is a C corp and you can look through the structure. Talk to your CPA.
Documentation is the difference between a benefit you can claim and a benefit you can’t. This applies to both sides. For QSBS, you need contemporaneous evidence that the company qualified at issuance. For 1244, you need to be able to show original-issue purchase, the corporation’s small-business-corporation status, and the active-business test. Keep your investment documents, keep founder communications about QSBS attestations, and keep records of the company’s status over time.
The two provisions can apply to the same stock. A single investment can qualify under Section 1202 if it wins and Section 1244 if it loses, provided the conditions for each are met. They’re not mutually exclusive — they’re complementary tools that address different outcomes.
Run the math early, not late. The most common mistake I’ve seen in my own circle is people thinking about QSBS or 1244 only at the moment of exit or write-off, when documentation and structure are already locked in. The benefits are determined at issuance and tested over the holding period. Running the analysis when you make the investment — confirming C-corp status, getting written QSBS attestation, understanding the gross asset position — costs almost nothing and protects benefits that can be enormous later.
Summary
The combination of Section 1202 and Section 1244 turns serves to juice an already interesting asset class. The winners pay less in federal tax than almost any other gain you can produce. The losers, within limits, soften your ordinary income bill in the year they’re recognized. The asset class is structured by the power law, but the tax code amplifies the math.
Most angels I know discover one of these two provisions and not the other — usually QSBS, because the upside is more exciting to talk about. The investors who do best are the ones who plan for both at the moment of investment: structuring the deal to qualify for QSBS if it wins, ensuring 1244 conditions are documented in case it loses, and treating the tax planning as part of the underwriting rather than a separate post-hoc exercise.
Again let me remind you that I can’t be trusted to get all the groceries on our weekly shopping list. I definitely can’t give tax advice . This piece is our experience and a general overview. The rules are specific, the documentation requirements are real, and your situation is yours alone. None of this is tax advice. Get a CPA who understands QSBS and 1244, ideally before you write your next check, and let them show you what’s possible in your specific case. The numbers, when this works, are big enough to be worth the meeting.